pd 153035 has been researched along with Colonic Neoplasms in 3 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karnes, WE | 1 |
| Weller, SG | 1 |
| Adjei, PN | 1 |
| Kottke, TJ | 1 |
| Glenn, KS | 1 |
| Gores, GJ | 1 |
| Kaufmann, SH | 1 |
| Bos, M | 1 |
| Mendelsohn, J | 1 |
| Kim, YM | 1 |
| Albanell, J | 1 |
| Fry, DW | 1 |
| Baselga, J | 1 |
| Pai, R | 1 |
| Soreghan, B | 1 |
| Szabo, IL | 1 |
| Pavelka, M | 1 |
| Baatar, D | 1 |
| Tarnawski, AS | 1 |
3 other studies available for pd 153035 and Colonic Neoplasms
| Article | Year |
|---|---|
Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells.
Topics: Apoptosis; Colonic Neoplasms; Endopeptidases; Enzyme Inhibitors; ErbB Receptors; Humans; Ligands; Pr | 1998 |
PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Enzyme Inhibitors; Er | 1997 |
Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.
Topics: Animals; Cell Line; Colonic Neoplasms; Dinoprostone; Enzyme Inhibitors; ErbB Receptors; Gastric Muco | 2002 |